|
QuintilesIMS Real-World Insights Bibliography
| Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. |
| Author(s): Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1. |
| Affiliations(s): 1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden.
2Centre for Observational Research, Amgen Ltd, Uxbridge, UK.
3IMS Health Sweden, Stockholm, Sweden.
|
| Publication(s): Clinical Epidemiology |
| Document Type(s): Article |
| Countries: Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK |
| Click here for the abstract |
C:
Y: |
Oncology
2016 |
|
L:
A: |
English
Literature Review |
|
 |
| |
| |
| Rationale and design of a multi-center survey to evaluate productivity losses and indirect costs after cardiovascular events in Europe. |
| Author(s): Gerlier L1, Sidelnikov E2, Kutikova L2, Lamotte M1, Annemans L3 |
| Affiliations(s): 1 QuintilesIMS, Zaventem, Belgium 2 Amgen (Europe) GmbH, Zug, Switzerland 3 University of Ghent, Ghent, Belgium |
| Publication(s): 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria |
| Document Type(s): Abstract |
| Countries: Belgium, Czech, France, Germany, Hungary, Italy, Poland, Portugal, Romania, Spain, Switzerland, UK |
C:
Y: |
Cardiovascular disease
2016 |
|
L:
A: |
English
|
|
|
| |
| |
| Survey on appropriateness of use of nimesulide in nine European countries |
| Author(s): Franchi S1, Heiman F2, Visentin E2, Sacerdote P1. |
| Affiliations(s): 1Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy.
2Cegedim Strategic Data Medical Research Srl, Milan, Italy. |
| Publication(s): Drug, Healthcare and Patient Safety 2015:7 51-55 |
| Document Type(s): Article |
| Countries: Bulgaria, Czech, Greece, Hungary, Italy, Poland, Portugal, Romania, Slovakia |
C:
Y: |
Pain
2015 |
|
L:
A: |
English
Survey research |
|
|
| |
| |
| Health economic evaluation of canagliflozin in the treatment of type 2 diabetes mellitus in Czech Republic |
| Author(s): Troelsgaard A1, Pitcher A2, Veselá Š3, Lovato E2, Hemels M1
|
| Affiliations(s): Janssen A/S, Birkerød, Denmark, 2IMS Health, London, UK, 3Janssen-Cilag Czech Republic, Prague, Czech Republic |
| Publication(s): ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
| Document Type(s): Poster |
| Countries: Czech |
C:
Y: |
Diabetes
2014 |
|
L:
A: |
English
Economic evaluation |
|
|
| |
| |
| Long-term clinical and cost outcomes of treatment with insulin detemir plus insulin aspart in type 1 diabetes patients in the Czech setting; data from the predictive study |
| Author(s): 1Clegg JP, 1Valentine WJ, 2Rychna K, 3Honka M, 4Doležal T |
| Affiliations(s): 1IMS, Allschwil, Switzerland, 2Novo Nordisk s.r.o, Praha 6, Czech Republic, 3Faculty Hospital
Ostrava, Ostrava, Czech Republic, 4Charles University in Prague, Prague 10, Czech Republic |
| Publication(s): ISPOR 2008 13th Annual International Congress |
| Document Type(s): Poster |
| Countries: Czech |
C:
Y: |
Diabetes
2008 |
|
L:
A: |
English
Cost effectiveness |
|
|
| |
| |
|
|
|
